Adverum Biotechnologies, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q1 2019 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Adverum Biotechnologies, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q1 2019 to Q3 2024.
  • Adverum Biotechnologies, Inc. Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2024 was $50.7M, a 3.91% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $50.7M -$2.06M -3.91% Sep 30, 2024 10-Q 2024-11-04
Q2 2024 $51.2M -$7.05M -12.1% Jun 30, 2024 10-Q 2024-08-12
Q1 2024 $51.8M -$17.7M -25.5% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $52.3M -$26.7M -33.8% Dec 31, 2023 10-Q 2024-11-04
Q3 2023 $52.8M -$27.1M -34% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $58.3M -$25.5M -30.4% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 $69.5M -$15.4M -18.1% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 $78.9M -$7.07M -8.22% Dec 31, 2022 10-K 2024-03-18
Q3 2022 $79.9M -$20.3M -20.3% Sep 30, 2022 10-Q 2022-11-10
Q2 2022 $83.8M -$18.1M -17.8% Jun 30, 2022 10-Q 2022-08-11
Q1 2022 $84.9M +$65.8M +346% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 $86M +$66.6M +344% Dec 31, 2021 10-K 2023-03-30
Q3 2021 $100M +$80.5M +409% Sep 30, 2021 10-Q 2021-11-04
Q2 2021 $102M +$81.9M +409% Jun 30, 2021 10-Q 2021-08-05
Q1 2021 $19M -$1.36M -6.68% Mar 31, 2021 10-Q 2021-05-06
Q4 2020 $19.4M -$1.59M -7.57% Dec 31, 2020 10-K 2022-03-29
Q3 2020 $19.7M -$1.81M -8.43% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 $20M -$2.04M -9.26% Jun 30, 2020 10-Q 2020-08-10
Q1 2020 $20.4M -$2.19M -9.68% Mar 31, 2020 10-Q 2020-05-28
Q4 2019 $21M Dec 31, 2019 10-K 2021-03-01
Q3 2019 $21.5M Sep 30, 2019 10-Q 2019-11-07
Q2 2019 $22.1M Jun 30, 2019 10-Q 2019-08-08
Q1 2019 $22.6M Mar 31, 2019 10-Q 2019-05-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.